Angiotensin-Receptor Blocker, Angiotensin-Converting Enzyme Inhibitor, and Risks of Atrial Fibrillation: A Nationwide Cohort Study

Both angiotensin-receptor blockers (ARB) and angiotensin-converting enzyme inhibitors (ACEI) have protective effects against atrial fibrillation (AF). The differences between ARB and ACEI in their effects on the primary prevention of AF remain unclear. This study compared ARB and ACEI in combined an...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Medicine (Baltimore)
Glavni autori: Hsieh, Yu-Cheng, Hung, Chen-Ying, Li, Cheng-Hung, Liao, Ying-Chieh, Huang, Jin-Long, Lin, Ching-Heng, Wu, Tsu-Juey
Format: Artigo
Jezik:Inglês
Izdano: Wolters Kluwer Health 2016
Teme:
3400
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4902433/
https://ncbi.nlm.nih.gov/pubmed/27196491
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000003721
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items